Comment
The X-ray analysis reports for the isolates from Ajuga lupulina, viz. lupulin A (Chen et al., 1997) and lupulin D (also called clerodinin B; Lin et al., 1989) , show contradictory graphical information. The simpler structure of lupulin D, as shown in (Fig. 1 of the paper = Fig. 1a here), could be described as 15-methoxydihydroclerodin (but is named 3-deoxy-14,15-dihydro-15-methoxycaryoptinol). The formula shows the corresponding neoclerodane skeleton with a few stereochemistries undisclosed. The 15-methoxy substitution (discussed as C17 in the Comment, according to the atomnumbering scheme in Fig. 1 of the paper) was 'in agreement with the structural elucidation of Lin et al. (1989) '. However, this Fig. 1 displays the view with displacement ellipsoids of an ent-neoclerodane structure with a 15-methoxy substitution. Thus, the deposited atomic coordinates must correspond to the inverted enantiomer of lupulin D [Cambridge Structural Database (Allen, 2002) refcode TEHZOV, Fig. 1b] and, further, the correct stereoformulae should be revised to 15-methoxydihydroclerodin [see revised lupulin D in Fig. 1c] . As a consequence, the early C-15 stereochemical assignments for clerodinins A and B (Lin et al., 1989) must also be reversed. The reversal of the previously assigned stereochemistries at position C-15 for both clerodinins A and B (change from to and from to , respectively), was already proposed by Ben Jannet et al. (1999) from the results of NMR NOESY experiments reported for hativenes A-C.
The structures of lupulin A and lupulin B were first elucidated by spectroscopic means (Chen, Tan, Liu, Zhang & Yang, 1996) and reported as 15-methoxy ( showed strong antibacterial activity, and accordingly, it should be the compound studied by means of X-ray crystallographic analysis (Chen et al., 1997) (confirmed by melting point and empirical formula). This X-ray report shows the neoclerodane structure of 15-methoxydihydroajugapitin (Fig. 2b ) in the view with displacement ellipsoids. In this instance, quite unexpectedly, opposite graphical displays were again shown. There, the stereoformula displayed was the inverted enantiomer ent-neoclerodane 15-methoxydihydroajugapitin (Fig. 2c) . Furthermore, this X-ray structure already points out the reversal of the previously assigned stereochemistries at position C-15 for lupulins A and B (change from to and from to , respectively), based on NMR data. As already mentioned for clerodinins A and B, the reversal of the stereochemistries at C-15 for lupulins A and B had been already proposed from the results of NMR NOESY experiments (Ben Jannet et al., 1999 , 2000 . Unfortunately, the structure depicted in both papers for lupulin A (as shown in Fig. 3 ) was yet the uncorrected 15-methoxydihydroajugapitin analogous to hativene A, rather than the revised proposal analogous to hativene B.
In summary, lupulin A should display a revised 15-methoxyneoclerodane structure (Fig. 2b) , whereas lupulin B and lupulin D (Fig. 1c) display a 15-methoxy neoclerodane structure.
Note added in proof. The authors acknowledge Professor Hichem Ben Jannet for kindly providing a reprint (Ben Jannet et al., 2002) reporting the 'Structure of a new neoclerodane diterpenoid from Ajuga pseudoiva'. The compound was named hativene D, being in fact elucidated as the 15-epimer (15-MeO) of the uncorrected structure reported for lupulin A (Fig. 3d, 15-MeO) . However, the reported NMR data (an extended set showing a few corrections and assignment changes likely based on HMQC or HMBC spectroscopic data) match, not unexpectedly, quite well those of lupulin A, since the proposed structure revision points out the identical nature of hativene D and lupulin A.
